Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(3)

Detailed Status

Withdrawn2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

terminated125%
withdrawn250%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

NCT02670837
withdrawnnot_applicable

Allogeneic Skin Grafting

NCT04015947
terminatednot_applicable

Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study

NCT02150863
withdrawnnot_applicable

Effectiveness of CelluTome Epidermal Harvesting System in Autologous Skin Grafting of Chronic Wound Patients

NCT02492048

Clinical Trials (4)

Showing 4 of 4 trials
NCT02670837Not Applicable

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

Completed
NCT04015947Not Applicable

Allogeneic Skin Grafting

Withdrawn
NCT02150863Not Applicable

Treatment of Field Cancerization for Reduction in Tumor Burden - A Prospective Study

Terminated
NCT02492048Not Applicable

Effectiveness of CelluTome Epidermal Harvesting System in Autologous Skin Grafting of Chronic Wound Patients

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4